Cargando…
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death throughout the world. Due to the shortcomings of traditional chemotherapy, targeted therapies have come into prominence for the management of NSCLC. In particular, epidermal growth factor receptor (EGFR) tyrosine kinase...
Autores principales: | Özdemir, Ahmet, Ciftci, Halilibrahim, Sever, Belgin, Tateishi, Hiroshi, Otsuka, Masami, Fujita, Mikako, Altıntop, Mehlika Dilek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778314/ https://www.ncbi.nlm.nih.gov/pubmed/35056800 http://dx.doi.org/10.3390/molecules27020485 |
Ejemplares similares
-
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors
por: Sever, Belgin, et al.
Publicado: (2020) -
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2018) -
EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy
por: Ciftci, Halil I., et al.
Publicado: (2021) -
Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2017) -
Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents
por: Karabacak, Muhammed, et al.
Publicado: (2015)